Smit EF - Search Results

1

Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460.

Huisman C, Ferreira CG, Bröker LE, Rodriguez JA, Smit EF, Postmus PE, Kruyt FA, Giaccone G. Huisman C, et al. Among authors: smit ef. Clin Cancer Res. 2002 Feb;8(2):596-606. Clin Cancer Res. 2002. PMID: 11839682

2

A phase II study of high dose epirubicin in unresectable non small cell lung cancer.

Smit EF, Berendsen HH, Piers DA, Smeets J, Riva A, Postmus PE. Smit EF, et al. Br J Cancer. 1992 Mar;65(3):405-8. doi: 10.1038/bjc.1992.82. Br J Cancer. 1992. PMID: 1313691 Free PMC article. Clinical Trial.

3

In vitro response of human small-cell lung-cancer cell lines to chemotherapeutic drugs; no correlation with clinical data.

Smit EF, de Vries EG, Timmer-Bosscha H, de Leij LF, Oosterhuis JW, Scheper RJ, Weening JJ, Postmus PE, Mulder NH. Smit EF, et al. Int J Cancer. 1992 Apr 22;51(1):72-8. doi: 10.1002/ijc.2910510115. Int J Cancer. 1992. PMID: 1314232

4

Second-line carboplatin-based chemotherapy for small cell lung cancer: the Groningen experience.

Postmus PE, Smit EF, Berendsen HH, Haaxma-Reiche H. Postmus PE, et al. Among authors: smit ef. Semin Oncol. 1992 Feb;19(1 Suppl 2):17-23. Semin Oncol. 1992. PMID: 1329219 Clinical Trial.

5

Phase I study of oral teniposide (VM-26).

Smit EF, Ousterhuis BE, Berendsen HH, Sleijfer DT, Postmus PE. Smit EF, et al. Semin Oncol. 1992 Apr;19(2 Suppl 6):35-9. Semin Oncol. 1992. PMID: 1329226

6

Treatment of brain metastases of small cell lung cancer with teniposide.

Postmus PE, Smit EF, Berendsen HH, Sleijfer DT, Haaxma-Reiche H. Postmus PE, et al. Among authors: smit ef. Semin Oncol. 1992 Apr;19(2 Suppl 6):89-94. Semin Oncol. 1992. PMID: 1329230

7

Phase II study of high-dose epirubicin and etoposide in advanced non-small cell lung cancer.

Smit EF, Piers DA, Postmus PE. Smit EF, et al. Eur J Cancer. 1992;28A(12):1965-7. doi: 10.1016/0959-8049(92)90238-w. Eur J Cancer. 1992. PMID: 1329882 Clinical Trial.

8

Limitations of the fast green assay for chemosensitivity testing in human lung cancer.

Smit EF, de Vries EG, Meijer C, Mulder NH, Postmus PE. Smit EF, et al. Chest. 1991 Nov;100(5):1358-63. doi: 10.1378/chest.100.5.1358. Chest. 1991. PMID: 1657540

9

A feasibility study of testing new drugs for small-cell lung cancer in patients with a poor performance status.

Postmus PE, Smit EF, Berendsen HH, Sleyfer DT. Postmus PE, et al. Among authors: smit ef. Cancer Chemother Pharmacol. 1991;27(6):490-1. doi: 10.1007/BF00685167. Cancer Chemother Pharmacol. 1991. PMID: 1849466

10

Continuous infusion carboplatin on a 21-day schedule: a phase I and pharmacokinetic study.

Smit EF, Willemse PH, Sleijfer DT, Uges DR, Postmus PE, Meijer S, Terheggen PM, Mulder NH, de Vries EG. Smit EF, et al. J Clin Oncol. 1991 Jan;9(1):100-10. doi: 10.1200/JCO.1991.9.1.100. J Clin Oncol. 1991. PMID: 1985158

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

528 results

Search Page

Filters